GW Pharmaceuticals Aktie - GWPH

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

218,96

Gebot

218,95

Fragen

219,69

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

218,96

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

PAOG - PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand

May 20, 2021 -- InvestorsHub NewsWire -- via Market Screener -- Despite its micro-cap size, PAO Group, Inc. (USOTC: PAOG...

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc PR Newswire DUBLIN, May 5, 2021 DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz...

GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for En...

LONDON, April 29, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the...

GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals

LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz...

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associat...

– Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in Europe – – TSC causes...

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) ...

EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis...

BENZINGA (PAOG) - Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program

March 24, 2021 -- InvestorsHub NewsWire -- via Benzinga -- Are you looking to learn how to actually properly analyze stocks...

PAOG Undervalued With CBD Nutraceutical Partnerships

Here’s Why PAO Group Inc. Stock Looks Tremendously Undervalued; Dividend And CBD-Based Nutraceuticals Partnerships Are Two...

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated w...

LONDON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

GWPH - Frequently Asked Questions (FAQ)

What is the current GW Pharmaceuticals share price?

The current share price of GW Pharmaceuticals is US$ 218,96

What is the 1 year trading range for GW Pharmaceuticals share price?

GW Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
RDUSRadius Recycling Inc	US$ 27,902 (104,26%)	8,53M
BONBon Natural Life Ltd	US$ 1,40 (90,29%)	84M
SUNESUNation Energy Inc	US$ 0,5213 (62,96%)	513,96M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 255,00 (39,80%)	222
AAOIApplied Optoelectronics Inc	US$ 22,105 (39,29%)	17,01M
GLSTUGlobal Star Acquisition Inc	US$ 2,00 (-69,23%)	421
CURRCurrenc Group Inc	US$ 2,03 (-41,33%)	1,42M
ADTXAditxt Inc	US$ 0,0201 (-39,82%)	240,2M
HEPAHepion Pharmaceuticals Inc	US$ 0,0228 (-39,68%)	161,52M
WKSPWorksport Ltd	US$ 0,36205 (-35,45%)	4,96M
SUNESUNation Energy Inc	US$ 0,5213 (62,96%)	513,96M
NVDANVIDIA Corporation	US$ 121,67 (5,27%)	277,56M
ADTXAditxt Inc	US$ 0,0201 (-39,82%)	240,2M
HEPAHepion Pharmaceuticals Inc	US$ 0,0228 (-39,68%)	161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9,225 (7,64%)	160,21M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

GW Pharmaceuticals PLC (GWPH)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

GWPH Neueste Nachrichten

PAOG - PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for En...

GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associat...

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) ...

BENZINGA (PAOG) - Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program

PAOG Undervalued With CBD Nutraceutical Partnerships

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated w...

GWPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

GW Pharmaceuticals PLC (GWPH) Börsenkurse

GW Pharmaceuticals PLC (GWPH)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

GWPH Neueste Nachrichten

PAOG - PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for En...

GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associat...

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) ...

BENZINGA (PAOG) - Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program

PAOG Undervalued With CBD Nutraceutical Partnerships

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated w...

GWPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR